Immunoglobulin free light chain levels and rituximab response in rheumatoid arthritis: Comment on the article by Sellam et al

被引：3
|
作者：
Tekstra, Janneke [1 ]
van Roon, Joel [1 ]
Kormelink, Tom Groot [2 ]
Redegeld, Frank [2 ]
机构：
[1] Univ Med Ctr, Utrecht, Netherlands
[2] Univ Utrecht, Utrecht, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 12期
关键词：
DISEASE-ACTIVITY; VALIDATION; SERUM;
D O I：
10.1002/art.30632
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4034 / 4035
页数：2
相关论文
共 20 条
  • [1] Are immunoglobulin free light chains levels reliable to assess disease activity in rheumatoid arthritis?
    Djidjik, Reda
    Messaoudani, Nesrine
    Raaf, Nabil
    Boudjella, Mohammed Lotfi
    Abdessmed, Amina
    Bahaz, Naima
    Rahal, Fadia
    Ladjouze, Aicha
    Ghaffor, Mohammed
    JOINT BONE SPINE, 2013, 80 (04) : 437 - 438
  • [2] Classifying remission in rheumatoid arthritis treat-to-target studies: comment on the article by Norvang et al
    Xie, Wenhui
    Zhang, Zhuoli
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1406 - 1407
  • [3] Is methotrexate as efficacious as etanercept in psoriatic arthritis patients? Comment on the article by Mease et al
    Kerschbaumer, Andreas
    Smolen, Josef S.
    Aletaha, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) : 1227 - 1229
  • [4] Judging disease activity in rheumatoid arthritis by serum free kappa and lambda light chain levels
    Ye, Yun
    Li, Su-Liang
    Xie, Ming
    Jiang, Ping
    Liu, Kai-Ge
    Li, Ya-Jun
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2013, 29 (10) : 547 - 553
  • [5] Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis"
    Talabot-Ayer, Dominique
    Gabay, Cem
    Palmer, Gaby
    JOINT BONE SPINE, 2013, 80 (01) : 117 - 118
  • [6] Functional capacity at 1 year predicts all-cause mortality in patients with rheumatoid arthritis: comment on the article by Fatima et al
    Jacoby, Richard K.
    Rasker, Johannes J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (01) : 177 - 178
  • [7] Elevation of Serum Immunoglobulin Free Light Chains During the Preclinical Period of Rheumatoid Arthritis
    Deng, Xiaoli
    Crowson, Cynthia S.
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Larson, Dirk R.
    Therneau, Terry M.
    Matteson, Eric L.
    Kyle, Robert A.
    Katzmann, Jerry A.
    Gabriel, Sherine E.
    Davis, John M., III
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (02) : 181 - 187
  • [8] Polyclonal Immunoglobulin Free Light Chain Levels Predict Survival in Myeloid Neoplasms
    Pardanani, Animesh
    Lasho, Terra L.
    Finke, Christy M.
    Rajkumar, S. Vincent
    Singh, Preet Paul
    Ketterling, Rhett P.
    Hanson, Curtis A.
    Katzmann, Jerry A.
    Tefferi, Ayalew
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (10) : 1087 - 1094
  • [9] CD8+T cell profiles in patients with rheumatoid arthritis-the effects of costimulation blockade: comment on the article by Carvalheiro et al
    Airo, Paolo
    Colombo, Enrico
    Piantoni, Silvia
    Scarsi, Mirko
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2273 - 2274
  • [10] Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
    Kormelink, T. Groot
    Tekstra, J.
    Thurlings, R. M.
    Boumans, M. H. J.
    Vos, K.
    Tak, P. P.
    Bijlsma, J. W. J.
    Lafeber, F. P. J. G.
    Redegeld, F. A.
    van Roon, J. A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2137 - 2144
12